Research ArticleCancer

Disrupting the CD47-SIRPα anti-phagocytic axis by a humanized anti-CD47 antibody is an efficacious treatment for malignant pediatric brain tumors

See allHide authors and affiliations

Science Translational Medicine  15 Mar 2017:
Vol. 9, Issue 381, eaaf2968
DOI: 10.1126/scitranslmed.aaf2968

Log in to view Figures & Data